Literature DB >> 10212020

Reversible akinetic mutism possibly induced by baclofen.

D I Rubin1, E L So.   

Abstract

A 76-year-old man developed akinetic mutism after 3 days of receiving low-dosage baclofen. Electroencephalography showed a diffusely slow background with intermittent generalized sharp wave discharges. The condition resolved after discontinuing baclofen. To our knowledge, this is the first reported case of baclofen-induced akinetic mutism in a patient with normal renal function. The pathophysiology of this condition is unknown, but it may result from selective binding of the drug to the gamma-aminobutyric acid-B receptors located in the frontal lobes or thalamic nuclei, interrupting the thalamocortical limbic pathways.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10212020     DOI: 10.1592/phco.19.6.468.31053

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  4 in total

1.  Akinetic mutism followed by a manic reaction on introduction of steroid replacement for Addison's disease.

Authors:  G Kalambokis; S Konitsiotis; D Pappas; E V Tsianos
Journal:  J Endocrinol Invest       Date:  2006-03       Impact factor: 4.256

Review 2.  A benefit-risk assessment of baclofen in severe spinal spasticity.

Authors:  Alessandro Dario; Giustino Tomei
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

3.  Encephalopathy and hypotonia due to baclofen toxicity in a patient with end-stage renal disease.

Authors:  Mohsin Ijaz; Hassan Tariq; Muhammad Kashif; Jose Gomez Marquez
Journal:  Am J Case Rep       Date:  2015-04-20

4.  Single-dose baclofen-induced neurotoxicity in a patient with end stage renal disease: case report.

Authors:  Emad Khazneh; Alaa Shamlawi; Kamel Jebrin; Zakaria Hamdan; Osama Sawalmeh
Journal:  BMC Nephrol       Date:  2018-12-11       Impact factor: 2.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.